These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2568662

  • 1. Pharmacokinetics of three different injectable zuclopenthixol preparations.
    Aaes-Jørgensen T.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):77-85. PubMed ID: 2568662
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
    Viala A, Ba B, Durand A, Gouezo F, Hou N, Jørgensen A.
    Psychopharmacology (Berl); 1988; 94(3):293-7. PubMed ID: 2895936
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation and serum concentration of zuclopenthixol acetate in psychotic Asian patients: a single-dose preliminary study.
    Tan CH, Low BL, Ng LL, Khoo YM, Lee HS.
    Ther Drug Monit; 1993 Apr; 15(2):108-12. PubMed ID: 8099240
    [Abstract] [Full Text] [Related]

  • 4. Zuclopenthixol acetate (5% in 'Viscoleo'): single-dose treatment for acutely disturbed psychotic patients.
    Chakravarti SK, Muthu A, Muthu PK, Naik P, Pinto RT.
    Curr Med Res Opin; 1990 Apr; 12(1):58-65. PubMed ID: 1971560
    [Abstract] [Full Text] [Related]

  • 5. Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses.
    Coutinho E, Fenton M, Quraishi S.
    Cochrane Database Syst Rev; 2000 Apr; 1999(2):CD001164. PubMed ID: 10796607
    [Abstract] [Full Text] [Related]

  • 6. Serum concentrations and clinical effect of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in Viscoleo.
    Amdisen A, Aaes-Jørgensen T, Thomsen NJ, Madsen VT, Nielsen MS.
    Psychopharmacology (Berl); 1986 Apr; 90(3):412-6. PubMed ID: 2878462
    [Abstract] [Full Text] [Related]

  • 7. Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation-an observational study including 2044 patients.
    Tveito M, Smith RL, Molden E, Høiseth G.
    Eur J Clin Pharmacol; 2021 Feb; 77(2):215-221. PubMed ID: 33000414
    [Abstract] [Full Text] [Related]

  • 8. Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses.
    Fenton M, Coutinho ES, Campbell C.
    Cochrane Database Syst Rev; 2000 Feb; (2):CD000525. PubMed ID: 10796549
    [Abstract] [Full Text] [Related]

  • 9. A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis.
    Baastrup PC, Alhfors UG, Bjerkenstedt L, Dencker SJ, Fensbo C, Gravem A, Pedersen V, Elgen K, Brekke B, Fredslund-Andersen K.
    Acta Psychiatr Scand; 1993 Jan; 87(1):48-58. PubMed ID: 8093824
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of zuclopenthixol acetate on psychotic anxiety evaluated in an open study].
    Romain JL, Dermain P, Greslé P, Grignon S, Moisan P, Nore D, Pech G, Benyaya J, Perret I.
    Encephale; 1996 Jan; 22(4):280-6. PubMed ID: 9035983
    [Abstract] [Full Text] [Related]

  • 11. A clinical assessment of zuclopenthixol dihydrochloride (Clopixol tablets) in the treatment of psychotic illness.
    Mann BS, Moslehuddin KS, Owen RT, Clayton AR, Rohatgi KK, Sud P, Vaddadi KS.
    Pharmatherapeutica; 1985 Jan; 4(6):387-92. PubMed ID: 2867559
    [Abstract] [Full Text] [Related]

  • 12. Zuclopenthixol acetate in Viscoleo--a new drug formulation. An open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses including mania and exacerbation of chronic psychoses.
    Amdisen A, Nielsen MS, Dencker SJ, Fensbo C, Ahlfors UG, Gravem A, Baastrup PC, Bjerkenstedt L, Gunby B, Wiesel FA.
    Acta Psychiatr Scand; 1987 Jan; 75(1):99-107. PubMed ID: 2883816
    [Abstract] [Full Text] [Related]

  • 13. Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo.
    Balant LP, Balant-Gorgia AE, Eisele R, Reith B, Gex-Fabry M, Garrone G.
    Pharmacopsychiatry; 1989 Nov; 22(6):250-4. PubMed ID: 2575763
    [Abstract] [Full Text] [Related]

  • 14. Zuclopenthixol decanoate in schizophrenia: serum levels and clinical state.
    Jørgensen A, Aaes-Jørgensen T, Gravem A, Amthor KF, Dencker SJ, Rosell I, Baastrup PC, Buckhave J, Gram LF.
    Psychopharmacology (Berl); 1985 Nov; 87(3):364-7. PubMed ID: 2867572
    [Abstract] [Full Text] [Related]

  • 15. Economic evaluation of zuclopenthixol acetate compared with injectable haloperidol in schizophrenic patients with acute psychosis.
    Laurier C, Kennedy W, Lachaine J, Gariepy L, Tessier G.
    Clin Ther; 1997 Nov; 19(2):316-29. PubMed ID: 9152570
    [Abstract] [Full Text] [Related]

  • 16. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
    Viala A, Hou N, Ba B, Durand A, Dufour H, D'Agostino N, Berda C, Jørgensen A.
    Psychopharmacology (Berl); 1984 Nov; 83(2):147-50. PubMed ID: 6146995
    [Abstract] [Full Text] [Related]

  • 17. An open study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses.
    Fend I, Jochum W, Eberhardt G, König P.
    Schizophr Res; 1988 Nov; 1(5):359-61. PubMed ID: 2908705
    [No Abstract] [Full Text] [Related]

  • 18. [A new injectable delayed-action neuroleptic with sedative and antipsychotic action: cis-(Z)-clopenthixol decanoate. Clinical trials].
    Lambert PA, Chabannes JP.
    Encephale; 1984 Nov; 10(2):83-91. PubMed ID: 6381033
    [Abstract] [Full Text] [Related]

  • 19. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
    Chouinard G, Safadi G, Beauclair L.
    J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
    [Abstract] [Full Text] [Related]

  • 20. Zuclopenthixol acetate in viscoleo in acutely disturbed psychotic patients.
    Schlosberg A, Barr F.
    Isr J Psychiatry Relat Sci; 1991 Dec; 28(2):60-3. PubMed ID: 1682290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.